S-1/A: Complete Solaria Files Amendment No. 3 to Form S-1, Addressing Potential Stock Dilution and Related Party Transactions
S-1/A Filing
Complete Solaria's latest S-1/A filing highlights potential stock dilution from warrant exercises and resales, along with significant related party transactions.
Summary
- Complete Solaria filed an amendment to its Form S-1 registration statement.
- The filing addresses the potential issuance of up to 21,874,907 shares of common stock upon exercise of warrants.
- It also covers the resale of up to 33,894,518 shares of common stock and 13,249,907 warrants by selling securityholders.
- The document details several related party transactions, including reclassification of pre-funded PIPE, issuance of shares and warrants, and non-cash interest expenses.
- The filing mentions the potential for significant stock dilution due to the resale of shares, which could depress the market price.
- The company highlights that selling securityholders may still profit despite a price decline due to their lower purchase prices.
- The document includes financial statements for various periods, including the thirteen and thirty-nine weeks ended October 1, 2023, and the years ended December 31, 2022, 2021, and 2020.
Sentiment
Score: 4
Explanation: The document presents a mixed sentiment. While it highlights growth strategies, it also acknowledges significant losses, potential stock dilution, and reliance on related party transactions. The overall tone is cautiously optimistic but with clear risks.
Negatives
- The document highlights the potential for significant stock dilution due to the resale of shares, which could depress the market price.
- It notes that selling securityholders may still profit even if the stock price declines, while public securityholders may not.
Risks
- The document warns of potential stock price depression due to the large number of shares being offered for resale.
- It notes that selling securityholders may still profit even if the stock price declines, while public securityholders may not.
Future Outlook
The document does not contain a detailed future outlook, but mentions the company's growth strategy and its elements.
Industry Context
The document does not provide specific industry context beyond mentioning the competitive landscape and the influence of government regulations and policies.
Related Party Transactions
- Reclassification of pre-funded PIPE was transacted with a related party.
- Includes 1,315,287 shares of Series D-1 redeemable convertible preferred stock with a carrying value of $6.3 million, issued to related parties.
- Non-cash interest expense to related parties of $0.1 million and $0.4 million during the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and zero and $0.1 million during the three and nine months ended September 30, 2022, respectively.
- Gain on extinguishment of convertible notes and SAFEs includes other income from related parties of zero during each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero and $1.4 million during the three and nine months ended September 30, 2022, respectively.
- Issuance of forward purchase agreements includes other income from related parties of $0.3 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero for each of the three and nine months ended September 30, 2022.
- Change in fair value of forward purchase agreement liabilities includes other expense from related parties of $5.9 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero for each of the three and nine months ended September 30, 2022.
- Issuance of common stock in connection with forward purchase agreements includes other expense from related parties of $30.7 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero for each of the three and nine months ended September 30, 2022.
- Issuance of common stock bonus shares to related parties in connection with the Mergers includes other expense of $0.7 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and zero for each of the three and nine months ended September 30, 2022.
- Includes zero and $1.4 million of other income for the three and nine months ended September 30, 2022, respectively, recognized upon the conversion of related party convertible notes and SAFEs.
- Includes $0.7 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for bonus shares issued to related parties in connection with the Mergers.
- Includes $0.3 million of other income for each of the thirteen and thirty-nine weeks ended October 1, 2023 for forward purchase agreements entered into with related parties.
- Includes $5.9 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for forward purchase agreements entered into with related parties.
- Includes $30.7 million of other expense for each of the thirteen and thirty-nine weeks ended October 1, 2023 for shares issued to related parties in connection with the forward purchase agreements.
- Non-cash interest expense to related parties of $0.3 million, $0.7 million and $0.2 million during the years ended December 31, 2022, 2021 and 2020, respectively.
- Gain on extinguishment of convertible notes and SAFEs includes other income from related parties of $1.4 million, zero and zero during the years ended December 31, 2022, 2021 and 2020, respectively.
- Includes interest expense to related parties of $0.3 million, $0.7 million and $0.2 million during the years ended December 31, 2022, 2021 and 2020, respectively.
- Other income (expense), net includes other income from related parties of $1.4 million, zero and zero during the years ended December 31, 2022, 2021 and 2020, respectively.
- Includes 4,508,488 shares of Complete Solaria Common Stock issued to related parties.
- Includes 120,000 shares of Complete Solaria Common Stock issued to related parties.
- Includes interest expense to related parties of less than $0.1 million and $0.4 million during the thirteen and thirty-nine weeks ended October 1, 2023, respectively, and zero and $0.1 million during the three and nine months ended September 30, 2022, respectively.
- Other income (expense), net includes other expense, net to related parties of $36.9 million for each of the thirteen and thirty-nine weeks ended October 1, 2023, and other income, net of zero and $1.4 million during the three and nine months ended September 30, 2022, respectively.
- Includes $1.4 million of other income recognized upon the conversion of related party convertible notes and SAFEs.
Stakeholder Impact
- The document highlights the potential for significant stock dilution due to the resale of shares, which could depress the market price, impacting shareholders.
- It notes that selling securityholders may still profit even if the stock price declines, while public securityholders may not, creating a disparity in returns.
Next Steps
- The company intends to use the net proceeds from the exercise of the Warrants for general corporate purposes.
- The selling securityholders will determine when and how they will dispose of the shares of common stock registered for resale under this prospectus.
Key Dates
| Date | Description |
|---|---|
| 2016-02-29 | Date associated with Series B Warrants and other warrant-related terms. |
| 2018-12-01 | Date associated with TwoZeroOneEightBridgeNotesMember. |
| 2019-01-01 | Start date for financial data covering the year 2019. |
| 2019-12-31 | End date for financial data covering the year 2019. |
| 2020-01-01 | Start date for financial data covering the year 2020. |
| 2020-01-20 | Date associated with LoanAndSecurityAgreementMember. |
| 2020-01-31 | Date associated with SeriesC1WarrantsMember. |
| 2020-04-01 | Start date for PaycheckProtectionProgrammeLoanMember. |
| 2020-04-30 | End date for PaycheckProtectionProgrammeLoanMember. |
| 2020-06-29 | Date associated with SeriesBWarrantsMember. |
| 2020-12-31 | End date for financial data covering the year 2020. |
| 2021-01-01 | Start date for financial data covering the year 2021. |
| 2021-01-21 | Date associated with CurrentInsightMember. |
| 2021-04-01 | Start date for PaycheckProtectionProgrammeLoanMember. |
| 2021-04-30 | End date for PaycheckProtectionProgrammeLoanMember. |
| 2021-05-31 | Date associated with SVBCommonStockWarrantsMember. |
| 2021-07-01 | Start date for TwoZeroTwoOnePromissoryNotesMember. |
| 2021-07-22 | Date associated with TwoZeroTwoOnePromissoryNotesMember. |
| 2021-07-31 | End date for TwoZeroTwoOnePromissoryNotesMember. |
| 2021-08-31 | Date associated with PromissoryNoteCommonStockWarrantsMember. |
| 2021-10-01 | Start date for TwoZeroTwoOnePromissoryNotesMember. |
| 2021-10-31 | End date for TwoZeroTwoOnePromissoryNotesMember. |
| 2021-12-01 | Start date for SecuredCreditFacilityMember. |
| 2021-12-31 | End date for financial data covering the year 2021. |
| 2022-01-01 | Start date for financial data covering the year 2022. |
| 2022-02-01 | Start date for SecuredCreditFacilityMember. |
| 2022-02-28 | End date for SecuredCreditFacilityMember. |
| 2022-03-01 | Start date for SecuredCreditFacilityMember. |
| 2022-03-31 | End date for SecuredCreditFacilityMember. |
| 2022-06-01 | Start date for ConvertiblePromissoryNotesMember. |
| 2022-06-30 | End date for ConvertiblePromissoryNotesMember. |
| 2022-07-01 | Start date for financial data covering the period 2022-07-01 to 2022-09-30. |
| 2022-09-30 | End date for financial data covering the period 2022-07-01 to 2022-09-30. |
| 2022-10-01 | Start date for ConvertiblePromissoryNotesMember. |
| 2022-10-31 | End date for SolariaCommonStockMember. |
| 2022-11-01 | Start date for November2022CommonStockWarrantsMember. |
| 2022-11-04 | Date associated with SolariaAcquisitionMember. |
| 2022-11-30 | End date for November2022CommonStockWarrantsMember. |
| 2022-12-01 | Start date for SecuredCreditFacilityMember. |
| 2022-12-31 | End date for financial data covering the year 2022. |
| 2023-01-01 | Start date for financial data covering the year 2023. |
| 2023-01-31 | End date for TwoThousandAndTwentyThreeConvertibleNotesMember. |
| 2023-02-01 | Start date for SecuredCreditFacilityMember. |
| 2023-02-28 | End date for SecuredCreditFacilityMember. |
| 2023-03-01 | Start date for TwoThousandAndTwentyThreeConvertibleNotesMember. |
| 2023-03-16 | Date associated with IssueOfBonusSharesInConnectionWithMergerMember. |
| 2023-03-31 | End date for TwoThousandAndTwentyThreeConvertibleNotesMember. |
| 2023-05-01 | Start date for November2022CommonStockWarrantsMember. |
| 2023-05-11 | Date associated with IssueOfBonusSharesInConnectionWithMergerMember. |
| 2023-05-31 | End date for November2022CommonStockWarrantsMember. |
| 2023-06-01 | Start date for ConvertiblePromissoryNotesMember. |
| 2023-06-30 | End date for ConvertiblePromissoryNotesMember. |
| 2023-07-01 | Start date for financial data covering the period 2023-07-01 to 2023-10-01. |
| 2023-07-03 | Date associated with SeriesDFourRedeemableConvertiblePreferredStockMember. |
| 2023-07-18 | Date associated with SeriesBWarrantsMember. |
| 2023-07-31 | End date for July2023CommonStockWarrantsMember. |
| 2023-08-01 | Start date for PurchaseAgreementsMember. |
| 2023-08-24 | End date for PurchaseAgreementsMember. |
| 2023-09-01 | Start date for SettlementAgreementMember. |
| 2023-09-28 | Date associated with PolarSettlementAgreementMember. |
| 2023-09-30 | End date for SettlementAgreementMember. |
| 2023-10-01 | End date for financial data covering the period 2023-07-01 to 2023-10-01. |
| 2023-10-31 | End date for SolariaCommonStockMember. |
| 2024-02-01 | Date of the prospectus. |
Keywords
shares, warrants, related party transactions, stock dilution, resale, common stock, Complete Solaria, S-1/A filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.